Wolverine Trading
MYGN icon

Wolverine Trading’s Myriad Genetics MYGN Stock Holding History

Wolverine Trading’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,800
Closed -$542K – 6707
2021
Q2 		$542K Buy
+17,800
New +$514K ﹤0.01% 3576
2020
Q3 		– Sell
-11,800
Closed -$130K – 4925
2020
Q2 		$130K Sell
11,800
-22,900
-66% -$325K ﹤0.01% 4037
2020
Q1 		$503K Buy
34,700
+2,000
+6% +$42.3K ﹤0.01% 2652
2019
Q4 		$867K Buy
32,700
+2,400
+8% +$66K ﹤0.01% 2551
2019
Q3 		$863K Sell
30,300
-14,300
-32% -$417K ﹤0.01% 2108
2019
Q2 		$1.24M Buy
+44,600
New +$1.26M ﹤0.01% 1861
2018
Q4 		– Sell
-10,400
Closed -$478K – 5040
2018
Q3 		$478K Sell
10,400
-24,700
-70% -$1.1M ﹤0.01% 3166
2018
Q2 		$1.04M Hold
35,100
– – ﹤0.01% 2237
2018
Q1 		$1.04M Buy
35,100
+21,400
+156% +$724K ﹤0.01% 2237
2017
Q4 		$471K Sell
13,700
-13,100
-49% -$442K ﹤0.01% 3072
2017
Q3 		$970K Sell
26,800
-20,100
-43% -$573K ﹤0.01% 1942
2017
Q2 		$1.2M Buy
46,900
+26,600
+131% +$565K 0.01% 1592
2017
Q1 		$388K Sell
20,300
-7,700
-28% -$136K ﹤0.01% 2700
2016
Q4 		$467K Buy
28,000
+11,200
+67% +$203K ﹤0.01% 2713
2016
Q3 		$348K Sell
16,800
-9,900
-37% -$251K ﹤0.01% 3026
2016
Q2 		$816K Buy
+26,700
New +$928K ﹤0.01% 1768

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wolverine Trading's MYGN Position: Q3 2019 in Review

Wolverine Trading sold out of Myriad Genetics (MYGN) in Q3 2019, closing a stake of 9,343 shares — an estimated $272K sold.

Wolverine Trading first reported a position in MYGN in Q2 2016 and held it in 2 quarters. The position peaked at $706K in Q2 2016. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2019.

  • Wolverine Trading reported no remaining Myriad Genetics position as of Q3 2019 after selling out during the quarter.
  • Wolverine Trading sold 9,343 Myriad Genetics shares in Q3 2019, an estimated $272K.
  • Wolverine Trading first reported a position in Myriad Genetics in Q2 2016 and held it in 2 quarters.
  • Wolverine Trading's Myriad Genetics position peaked at $706K in Q2 2016.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2019.

Based on Wolverine Trading's 13F filing for Q3 2019, filed 14 Nov 2019.